Rezolute ‘Thrilled’ With Positive Review Of Genetic Disorder Trial, Expects Topline Results In December – Rezolute (NASDAQ:RZLT)
Rezolute, Inc. RZLT on Wednesday announced the Independent Data Monitoring Committee’s (DMC) recommendation to continue the Phase 3 sunRIZE…